Pharma-Q Holdings Pty

What Pharma-Q Holdings Pty does

Pharma-Q Holdings (Pty) Ltd is a South African pharmaceutical contract manufacturer headquartered in Johannesburg at a 20,000+ square meter facility at 50 Commando Road, Industria West. Originally established in 1998 (formerly Cosi Pharmaceuticals SA), the company was acquired in November 2005 by a consortium comprising Micro Labs Group (India), The Siroya Group (UAE), and Holistic Remedies (South Africa). Pharma-Q operates three core manufacturing divisions — Steriles (eye/ear drops, ampoules, vials, dental cartridges, produced aseptically), Liquids/Creams/Ointments (oral syrups, suspensions, topical and vaginal formulations, haemodialysis products, veterinary suspensions), and Solids (tablets, capsules, powders, suspensions) — supplemented by an in-house contract testing laboratory offering microbiological and chemical analysis with stability programs, and regulatory services supporting product approvals.

The company is the only dental cartridge manufacturer in South Africa and one of a select few licensed steriles manufacturers, producing what it describes as the most diverse range of sterile dosage forms in the country. Its quality infrastructure is anchored by a Quality Control department of 40+ staff across Chemistry and Microbiology laboratories equipped with HPLC, GC, UV-VIS, FTIR, AA, TOC, laser diffraction particle size analysis, and other analytical instrumentation. Pharma-Q holds Medicines Control Council (MCC) approval, is the only South African manufacturer registered in Dubai, and is pursuing approvals across the GCC (Bahrain, Kuwait, Oman, Qatar, Saudi Arabia, UAE).

Pharma-Q generates revenue through three streams: contract manufacturing for established pharmaceutical companies (managed services), own-product sales of steriles, LCO, and solids into local and export markets, and contract testing services. Enterprise customers include Pfizer, Novartis, Bayer, B Braun, Aspen Pharmacare, Adcock Ingram, Cipla Medpro, Galderma, Ferring, and Smith & Nephew. Distribution is dual-channel: direct via an International Marketing Executive for exports and tenders, and through United Pharmaceutical Distributor for the South African private market, hospital groups, and dispensing doctors. A Ventures partner-network model extends effective manufacturing capacity without proportional capital outlay.

Name

Pharma-Q Holdings Pty

Legal name

Pharma-Q Holdings (Pty) Ltd

Website

https://pharmaq.co.za

Company type

Private

Founded year

1998

Operating status

Operating

Headcount range

11–50 employees

Short description

Pharma-Q Holdings is a Johannesburg-based pharmaceutical contract manufacturer serving enterprise pharma clients across steriles, liquids/creams/ointments, and solids, supported by in-house QC testing and active GCC export expansion.

Ownership category

akta.pro rank

Product category

Pharmaceutical Contract Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Primary Care & General Medicine Pharmaceuticals (HLAIAAAA)

akta.pro secondary industry

Clinical Quality Assurance (GCP QA, TMF/QMS oversight) (HLAGAKAI)

Keywords

• Pharmaceutical contract manufacturing
• Sterile dosage forms
• Oral solid dosage manufacturing
• Contract laboratory testing
• Regulatory pharmaceutical services

Headquarters

HQ city

Johannesburg

HQ country

South Africa

HQ region

Africa

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Infrastructure, Supply Chain, Technology or R&D, Marketing or Sales

Revenue model

1. Contract Manufacturing: Pharma-Q operates as a contract manufacturing business producing pharmaceutical products for established pharmaceutical companies in South Africa, providing manufacturing services under contracted arrangements
2. Contract Testing Services: QC department offers its services as a contract testing laboratory for both microbiological and chemical analysis, including stability programs for customers
3. Own Product Range: Development and sale of company's own product range including steriles, LCO, and solids products for local and global markets

Go-to-market motion2 records

Distribution channels2 records

Marketing channels3 records

Core offering

Pharma-Q Holdings is a South African pharmaceutical contract manufacturer that produces sterile dosage forms (eye/ear drops, ampoules, vials, dental cartridges), liquids/creams/ointments, and oral solid dosage forms (tablets, capsules, powders, suspensions) on behalf of established pharmaceutical companies. It also offers contract laboratory testing (chemical and microbiological analysis with stability programs), regulatory services for product approvals, and distributes a range of surgical products and disposables, while developing and selling its own product range to local and export markets including GCC countries.

Product overview

Pharma-Q Holdings Pty is a South African contract pharmaceutical manufacturing business offering a diversified portfolio of products and services. The core offering consists of three manufacturing divisions: Steriles (eye/ear drops, injectables including ampoules, vials, and dental cartridges), Liquids/Creams/Ointments (LCO), and Solids (tablets, capsules, powders, suspensions). Supporting services include a contract testing laboratory providing microbiological and chemical analysis, and regulatory services. The company also distributes a range of surgical products and disposables. Pharma-Q is the only dental cartridges manufacturer in South Africa and one of only a select few licensed steriles manufacturers in the country.

Differentiator

Problem solved

Functional benefit

Products and services

• Steriles Manufacturing Contract manufacturing of sterile pharmaceutical dosage forms including eye drops, ear drops, eye ointments, glass ampoules, vials, and dental cartridges, all filled aseptically. Targeted at pharmaceutical companies requiring MCC-licensed sterile production capacity.
• Liquids, Creams and Ointments (LCO) Manufacturing Contract manufacturing of liquids, creams and ointments including oral syrups, suspensions, gargles, sprays, topical and vaginal creams, topical ointments, topical and vaginal gels, haemodialysis products, and veterinary suspensions. For pharmaceutical companies needing LCO production capacity.
• Solids Manufacturing Contract manufacturing of solid oral dosage forms including tablets, capsules, powders, and suspensions for pharmaceutical companies.
• Contract Testing Laboratory Contract quality control laboratory providing chemical and microbiological analytical testing and stability programs for pharmaceutical customers, using HPLC, GC, UV-VIS, FTIR, AA, TOC and related instrumentation, plus sterility, bacterial endotoxin, preservative effectiveness, environmental monitoring and antibiotic assays.
• Regulatory Services Regulatory services supporting pharmaceutical product approvals and compliance, backed by the company's MCC approval and Dubai/GCC registration footprint.
• Surgical Products Distribution of medical equipment and disposable surgical products including stethoscopes, blood pressure instruments, hospital beds, syringes, IV sets, surgical instruments, and imaging equipment.

Named customers10 records

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

One partnership is on record.

• Ventures Partner CompaniescoreStrategic or Co-development PartnerPharma-Q's Ventures business model networks with partner companies to provide broad-based, seamless manufacturing services. Partners are selected based on quality, reliability, cost-effectiveness, service innovation, credibility, regulatory accreditation, and ethical standards. This model maximizes supply chain efficiencies by sourcing services across geographical boundaries.

Scale indicators5 records

Recent moves5 records

Expansion highlights5 records

Broad incumbents

• Recipharm: European CDMO with broad sterile and oral solid manufacturing capabilities serving global pharma clients. Comparable business model as a contract manufacturer of diverse dosage forms for established pharmaceutical companies.
• Delpharm: French-headquartered European CDMO providing contract manufacturing of sterile and non-sterile dosage forms for global pharmaceutical companies. Comparable business model as a multi-format CMO serving established pharma clients.
• Catalent: Global leading CDMO with extensive sterile, oral solid, and biologics manufacturing capabilities. Represents the scale benchmark Pharma-Q competes against for multinational pharma outsourcing contracts, particularly for steriles and aseptic filling.
• Lonza Group: Swiss-based global CDMO leader with significant steriles and biologics manufacturing capacity. Comparable to Pharma-Q in steriles focus but operates at vastly greater scale across global pharma clients.
• Cipla: Indian-headquartered global pharmaceutical manufacturer with extensive contract and own-brand manufacturing operations. Connected to Pharma-Q through Cipla Medpro as both a customer and a regional pharma manufacturing peer.
• Aenova Group: German pharmaceutical contract manufacturer with capabilities across solid, semi-solid, and sterile dosage forms. Comparable as a multi-format CDMO serving multinational pharma customers across diverse therapeutic categories.

Emerging players

• NextPharma: European CDMO specializing in sterile liquids, semi-solids, and oral solid dose contract manufacturing for pharma and consumer health clients. Comparable mid-sized CMO with multi-format capabilities and contract testing services.

Direct peers

• Aspen Pharmacare: South Africa's largest pharmaceutical manufacturer with extensive contract manufacturing and own-brand operations across steriles, solids, and biologics. Both companies serve overlapping multinational clients in the SA market and compete for similar CMO contracts.
• Adcock Ingram: Major South African pharmaceutical manufacturer with diversified portfolio across prescription, OTC, and hospital products including sterile manufacturing. A direct regional peer and also a Pharma-Q contract manufacturing customer.

Others

• Micro Labs Group: India-based top-15 pharmaceutical company and lead shareholder of Pharma-Q since 2005, with 12 manufacturing plants globally. Connected as parent and as a source of technology transfer, formulations, and potential volume allocation to the SA facility.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/pharma-q-manufacturing-pharmaceutical-company

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Pharma-Q Holdings Pty